Montelukast vs Osimertinib
Montelukast vs Osimertinib: Overview
This comparison examines the pharmacological differences between Montelukast and Osimertinib.
Mechanism of Action
Montelukast: Selective leukotriene D4 receptor antagonist.
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Montelukast β 2.7-5.5 hours; Osimertinib β 48 hours.
Chemical Properties
Molecular Formula: Montelukast β C35H36ClNO3S; Osimertinib β C28H33N7O2.
Molecular Weight: Montelukast β 586.1800 g/mol; Osimertinib β 499.6050 g/mol.
Type: Montelukast β Small molecule; Osimertinib β Small molecule.